This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| PubChem BioAssay | |
|---|---|
| Name | PubChem BioAssay |
| Owner | National Center for Biotechnology Information |
| Launch | 2004 |
| Type | Biological assays repository |
| Access | Public |
PubChem BioAssay is a publicly accessible database of biological assay descriptions and screening results hosted by the National Center for Biotechnology Information. It aggregates high-throughput screening, confirmatory, and profiling data contributed by academic laboratories, biotechnology companies, and government agencies to support chemical biology, drug discovery, and cheminformatics research. The resource interoperates with compound-centric and literature resources to enable cross-referenced queries across large-scale experimental datasets.
PubChem BioAssay functions as an assay-centric complement to compound and substance repositories, linking experimental outcomes to chemical structures curated in compound collections and to literature indexed in bibliographic services. The resource coordinates with institutions such as the National Institutes of Health, the National Library of Medicine, and international partners to collect datasets from screening centers, pharmaceutical consortia, and academic projects. Major contributors include organizations like the Broad Institute, the Scripps Research Institute, and consortia modeled after initiatives such as the Structural Genomics Consortium and the Molecular Libraries Program. The repository is integrated with indexing efforts exemplified by databases maintained by the European Bioinformatics Institute and the Protein Data Bank.
Records in the repository describe assay protocols, biological targets, experimental conditions, and activity endpoints linked to chemical entities cataloged in compound registries and substance databases. Each record typically associates with identifiers used by the Chemical Abstracts Service, the International Union of Pure and Applied Chemistry, and protein or gene entries cross-referenced through resources like UniProt, RefSeq, and Ensembl. Data fields accommodate high-throughput output formats produced by automated screening platforms developed at centers such as the National Center for Advancing Translational Sciences and commercial instrument manufacturers. Structural representations are harmonized with cheminformatics toolkits used in projects at the Royal Society of Chemistry and academic groups at institutions such as MIT and Stanford.
Contributors submit assay descriptions and result tables through submission pipelines overseen by repository staff and supported by tools adopted from projects at the Wellcome Trust, the Gates Foundation, and government-funded screening networks. Submissions undergo automated validation for schema compliance and are reviewed for completeness and metadata quality by curators with training comparable to staff in annotation teams at the European Molecular Biology Laboratory and the American Chemical Society. Curatorial decisions follow community guidelines influenced by standards bodies such as the World Health Organization and national research councils to ensure interoperability with databases like ChEMBL and DrugBank.
The database provides programmatic access via APIs patterned after web services used by projects at the National Cancer Institute, the Global Alliance for Genomics and Health, and genomics portals at the Wellcome Sanger Institute. Users can query by assay identifier, target protein, or chemical structure using search interfaces inspired by platforms at PubMed, Google Scholar, and Scopus, and can perform structure-based searches interoperable with cheminformatics systems developed at companies like OpenEye and academic groups at the University of California, San Diego. Integration pipelines enable cross-linking with pathway resources such as Reactome, signaling maps curated at EMBL-EBI, and clinical annotations appearing in databases maintained by the Food and Drug Administration and the European Medicines Agency.
Researchers employ the repository to prioritize screening hits for medicinal chemistry campaigns at pharmaceutical companies including Pfizer, Merck, and Novartis, and to validate biological hypotheses in academic laboratories at Harvard, Yale, and Johns Hopkins. Computational scientists leverage aggregated activity matrices for machine learning models developed in collaborations with institutions like Google DeepMind, IBM Research, and academic teams at Carnegie Mellon and ETH Zurich. Public health agencies and translational researchers reference assay outcomes when correlating chemical activities with phenotypes in resources such as ClinVar and the Human Protein Atlas.
Metadata schemas align with community standards promulgated by organizations like the Open Biological and Biomedical Ontology Foundry, the National Information Standards Organization, and the Research Data Alliance. Controlled vocabularies and ontologies used for assay annotation draw on principles from the Gene Ontology project, the Systems Biology Ontology, and chemical ontologies curated by the International Union of Pure and Applied Chemistry. Interoperability is supported through identifier mapping conventions shared with databases such as KEGG, BioGRID, and ArrayExpress.
Users should be aware of heterogeneity in assay design, variability in endpoint definitions, and batch effects common to datasets generated across different laboratories and platforms such as those used at high-throughput centers associated with EMBL-EBI and national screening hubs. Quality control measures include flagging of inconclusive or inconsistent results, comparators to curated datasets like ChEMBL, and provenance metadata similar to practices at the Library of Congress and national archives. Ongoing community efforts from academic consortia and regulatory agencies aim to improve reproducibility and standardization in the underlying datasets.
Category:Biological databases Category:National Center for Biotechnology Information Category:High-throughput screening